Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: notification
2012
PHARMAC documents that matched your search:
Decision to fund tramadol sustained release tablets; Contact: Notifications; Posted: 2012-12-21
(2 pages, 106 KB)
2012/12/21
21 December 2012 Decision to fund tramadol sustained release tablets PHARMAC is pleased to announce the approval of an agreement with CSL Biotherapies NZ Ltd to list tramadol sustained release tablets (Tramal SR) in Section B, and to amend the…
Decision to fund Paradigm X22 insulin pump and consumables; Contact: Notifications; Posted: 2012-12-20
(2 pages, 109 KB)
2012/12/20
20 December 2012 Decision to fund Paradigm X22 insulin pump and consumables PHARMAC is pleased to announce the approval of an agreement with Medtronic New Zealand Ltd for the funding of Paradigm X22 insulin pumps and related consumables. This was…
Decision to list posaconazole; Contact: Notifications; Posted: 2012-12-18
(2 pages, 111 KB)
2012/12/18
17 December 2012 Decision to list posaconazole PHARMAC is pleased to announce the approval of an agreement with Merck Sharp & Dohme (New Zealand) Limited to list posaconazole (Noxafil) oral suspension. This was the subject of a consultation letter dated…
Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing; Contact: Notifications; Posted: 2012-12-12
(3 pages, 108 KB)
2012/12/12
12 December 2012 Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing PHARMAC is pleased to announce the approval of a proposal to amend the criteria for accessing funding for the combination diphtheria, pertussis and tetanus vaccine (under…
Proposal involving Voluven and Volulyte 6% approved; Contact: Notifications; Posted: 2012-11-29
(2 pages, 114 KB)
2012/11/29
29 November 2012 Proposal involving Voluven and Volulyte 6% approved PHARMAC is pleased to announce the approval of the agreement with Fresenius Kabi New Zealand Limited regarding Voluven and Volulyte 6%. This was the subject of a consultation letter dated…
November Tender Notification; Contact: Notifications; Posted: 2012-11-27
(4 pages, 116 KB)
2012/11/27
27 November 2012 TENDER RESULTS The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2011/12 Invitation to Tender, dated 1…
Decision in relation to bosentan (Tracleer); Contact: Notifications; Posted: 2012-11-21
(2 pages, 123 KB)
2012/11/21
21 November 2012 Decision in relation to bosentan (Tracleer) PHARMAC is pleased to announce the approval of an agreement with Actelion Pharmaceuticals Australia Pty Limited in relation to bosentan (Tracleer). This was the subject of a consultation letter dated 1…
Decision in relation to the Sole Supply of Sildenafil (Silagra); Contact: Notifications; Posted: 2012-11-21
(2 pages, 123 KB)
2012/11/21
21 November 2012 Decision in relation to the Sole Supply of Sildenafil (Silagra) PHARMAC is pleased to announce the approval of an agreement with Arrow Pharmaceuticals (NZ) Limited in relation to sildenafil (Silagra). This was the subject of a consultation…
Approval of proposal to list Atripla and Truvada; Contact: Notifications; Posted: 2012-11-13
(2 pages, 115 KB)
2012/11/13
13 November 2012 Approval of proposal to list Atripla and Truvada PHARMAC is pleased to announce that the approval of an agreement with Gilead Sciences NZ. This was the subject of a consultation letter dated 8 October 2012. In summary,…
Notification to remove the Special Authority Criteria from various oncology products and pioglitazone; Contact: Notifications; Posted: 2012-11-12
(2 pages, 107 KB)
2012/11/12
12 November 2012 Decision on proposal to remove the Special Authority Criteria from various oncology products and pioglitazone PHARMAC is pleased to announce the approval of a proposal to widen funded access on a number of products from 1 December…
